Hypertrophy: Clinical Trials

371 trials for Hypertrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

209 completed, 66 unknown, 40 recruiting, 17 terminated. 137 Not applicable, 45 Phase 2, 40 Phase 4, 30 Phase 3, 17 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable137Completed 84, Unknown 20, Recruiting 11, Active not recruiting 8, Not yet recruiting 7, Enrolling by invitation 3, Withdrawn 2, Suspended 1, Terminated 1
Phase 245Completed 23, Recruiting 7, Unknown 5, Terminated 4, Withdrawn 4, Active not recruiting 2
Phase 440Completed 27, Unknown 6, Terminated 4, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 330Completed 15, Unknown 7, Terminated 5, Withdrawn 2, Active not recruiting 1
Phase 117Completed 8, Recruiting 5, Terminated 2, Unknown 2
Early Phase 12Completed 1, Recruiting 1

Follow Hypertrophy: new trials by email Literature Review of Hypertrophy trials Research Report on Hypertrophy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Implications of CMR Low Native T1 in Non-treated Non-hypertrophic Females With Fabry Disease (FD)
Decision tree for initiating treatment - Fabry Disease
Not applicableNot yet recruitingUniversity Hospital, Bordeaux602026-11-012026-10-14
Diode Laser Versus Conventional Frenectomy in Children
Diode Laser Frenectomy, Conventional Scalpel Frenectomy - Frenulum; Hypertrophy, Diode Laser
Not applicableNot yet recruitingYuzuncu Yil University202026-11-012026-10-02
A Study of Selective Internal Radiation Therapy for the Management of Chemotherapy-induced Thrombocytopenia With Splenomegaly in Adult Subjects With Gastrointestinal Cancer
TheraSphere - Gastrointestinal Cancer
Not applicableNot yet recruitingCentre Georges Francois Leclerc182026-10-012026-05-13
Comparison Between Eccentric Hamstring Training and Sprint-Specific Training
RDL, NHE, Sprint testing - Healthy Adult, Athlete
Not applicableNot yet recruitingUniversity of Wisconsin, Madison902026-10-012026-10-27
ATR 1072 in Participants With PRKAG2 Syndrome
ATR 1072 - Cardiac Glycogenosis, Cardiomyopathy
Phase 1 / Phase 2RecruitingAtrium Therapeutics372026-09-142026-09-18
Detection of Cardiac Amyloidosis Using Right Ventricular Sensing Amplitude in Patients With Left Ventricular Hypertrophy
Cardiac amyloidosis screening during CIED implantation - Cardiac Amyloidosis, Left Ventricular Hypertrophy
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris2422026-09-012026-07-29
Can Exercise Electrocardiography Discriminate Hypertensive Heart Disease From Obstructive Coronary Artery Disease? A Multimodality Imaging Study
Obstructive Coronary Artery Disease, Left Ventricular Hypertrophy
RecruitingUniversity of Pisa302026-09-012026-09-29
Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)
Angiotensin Receptor Blocker (ARB) - Transcatheter Aortic Valve Replacement (TAVR), Left Ventricular Hypertrophy
Phase 4Not yet recruitingSeoul National University Hospital6322026-08-152026-07-29
Skeletal Muscle Adaptations to Peptide-Supplemented Resistance Exercise Training
Resistance Exercise Training with or without daily supplementation, Dual Energy X-Ray Absorptiometry (DEXA) Scan, Muscle Sampling - Supplement, Resistance Training Adaptation
Not applicableRecruitingUniversity of Birmingham242026-07-142026-08-21
Heart Rate Variability and Early Cytokine Profile in Pediatric Adenotonsillectomy
Heart Rate Monitoring, Vagal Bradycardia
Active not recruitingDuzce University762026-07-012026-07-22
AI-based Echocardiography for Detection of Cardiac Amyloidosis
AI-based echocardiogram - Cardiac Amyloidosis, Heart Failure With Preserved Ejection Fraction (HFPEF)
Not applicableNot yet recruitingGermans Trias i Pujol Hospital2002026-07-012026-06-12
Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
LX2006, Usual Care - Friedreich Ataxia, Cardiomyopathy, Secondary
Phase 2RecruitingLexeo Therapeutics262026-06-252026-09-02
Therapeutic RSK1 Targeting in Myeloid Malignancies
PMD-026 - Myeloid Malignancy
Phase 1RecruitingWashington University School of Medicine302026-05-202026-10-21
Longitudinal Prognosis of Lymphoproliferative Manifestations in Primary Immunodeficiencies
Primary Immune Deficiencies, Benign Lymphoproliferative Disorder
Not yet recruitingCentral Hospital, Nancy, France602026-04-012026-04-13
Resistance Training Adaptations and Caffeine Intake
Caffeine (Constant Daily Dose), Caffeine (Escalating Dose), Caffeine (Training Days Only) - Muscle Hypotrophy, Exercise Performance
Not applicableCompletedIstanbul University - Cerrahpasa1202026-02-202026-07-14
Left Ventricular Hypertrophy in CKD Patients
transthoracic echocardiography - Left Ventricular Hypertrophy
Not yet recruitingSohag University1002026-01-152026-02-02
Evaluation of the Efficacy of Diagnostic Support Algorithms in Chest X-rays- LuAna Trial
App LuAna - Consolidation, Lung Injury
Not applicableRecruitingHospital Israelita Albert Einstein24002026-01-052026-09-16
BFR Rope Training in Male Volleyball Players
Blood Pressure, Muscle Strength, Serve Speed - Volleyball, Performance
Not applicableNot yet recruitingKarabuk University262025-12-112026-01-08
Fish Oil, Metformin and Heart Health in PCOS
Fish oil, Metformin, Fish Oil and Metformin - PCOS, Cardiovascular Disease
Phase 1RecruitingUniversity of Alberta1462025-11-012025-12-12
US Benchmarking Clinical Study
HFpEF - Heart Failure With Preserved Ejection Fraction, HFmrEF
RecruitingeMyosound SAS1502025-09-162025-10-20

Showing 20 of 371. Sign in to see all of them.

Narrower conditions

Hypertrophy, Left Ventricular (162)  ·  Hypertension (53)  ·  Splenomegaly (41)  ·  Heart Failure (31)  ·  Cardiomegaly (30)  ·  Cardiomyopathy, Hypertrophic (25)  ·  Cardiovascular Diseases (25)  ·  Cardiomyopathies (22)  ·  Aortic Valve Stenosis (17)  ·  Kidney Failure, Chronic (14)  ·  Cicatrix (13)  ·  Heart Diseases (13)  ·  Hepatomegaly (12)  ·  Renal Insufficiency, Chronic (12)

Broader conditions

Pathological Conditions, Anatomical (371)  ·  Pathological Conditions, Signs and Symptoms (371)  ·  Heart Diseases (198)  ·  Cardiovascular Diseases (193)  ·  Cardiomegaly (167)  ·  Vascular Diseases (92)  ·  Pathologic Processes (72)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (56)  ·  Nutritional and Metabolic Diseases (47)  ·  Nervous System Diseases (45)  ·  Aortic Valve Disease (43)  ·  Genetic Diseases, Inborn (43)  ·  Heart Valve Diseases (43)  ·  Metabolic Diseases (41)

Interventions

Resistance Training (13)  ·  Valsartan (9)  ·  Blood Specimen Collection (7)  ·  Exercise (6)  ·  Losartan (6)  ·  Amlodipine (5)  ·  ruxolitinib (5)  ·  Echocardiography (4)  ·  Eplerenone (4)  ·  Tadalafil (4)  ·  Whey Proteins (4)  ·  paricalcitol (4)  ·  11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (3)  ·  Allopurinol (3)  ·  Atenolol (3)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (11)  ·  Novartis Pharmaceuticals (5)  ·  Assistance Publique - Hôpitaux de Paris (4)  ·  Indiana University (4)  ·  M.D. Anderson Cancer Center (4)  ·  Massachusetts General Hospital (4)  ·  University of British Columbia (4)  ·  University of Dundee (4)  ·  Washington University School of Medicine (4)  ·  AVAVA, Inc. (3)  ·  Assiut University (3)  ·  Brigham and Women's Hospital (3)  ·  CENTOGENE GmbH Rostock (3)  ·  Ege University (3)  ·  First Affiliated Hospital Xi'an Jiaotong University (3)

Countries

United States (117)  ·  United Kingdom (32)  ·  France (25)  ·  Germany (24)  ·  Canada (23)  ·  Turkey (Türkiye) (22)  ·  Italy (21)  ·  China (19)  ·  Brazil (17)  ·  Denmark (15)  ·  Czechia (11)  ·  Spain (11)  ·  Australia (10)  ·  Belgium (10)  ·  Russia (10)

Top investigators

Ercan Ok, MD (3)  ·  Jianjun Mu, doctor (3)  ·  Peter Bauer, Prof. (3)  ·  Alexei Wong (2)  ·  Andrew M South, MD MS (2)  ·  Andrew T Yan, MD (2)  ·  Elisa Giannetta, MD - Phd (2)  ·  Franz Schaefer, MD (2)  ·  Frederik Nevens, MD, PhD (2)  ·  Graydon S Meneilly, MD (2)  ·  Loes van Keimpema, MSc (2)  ·  Matthew Gronski (2)  ·  Peter Juhl-Olsen, M.D. (2)

Results publications

PMID 17075116, PMID 18591942, PMID 22978814, PMID 23059770, PMID 32380558, PMID 33275766, PMID 36822394, PMID 39356039, PMID 10028970, PMID 10030657, PMID 10199738, PMID 10213344, PMID 10450601, PMID 10556226, PMID 10594802, PMID 10598732, PMID 10678860, PMID 10802712, PMID 10830164, PMID 10908222, PMID 10940788, PMID 10952828, PMID 11055975, PMID 11057898, PMID 11208620, PMID 11250334, PMID 11403367, PMID 11422885, PMID 11514367, PMID 11803349, PMID 12088775, PMID 12172314, PMID 12356407, PMID 12423712, PMID 12555153, PMID 12652219, PMID 12668503, PMID 12714020, PMID 12738602, PMID 12742978, PMID 12906982, PMID 12962864, PMID 13630833, PMID 1423934, PMID 14612424, PMID 14630977, PMID 14639093, PMID 14700505, PMID 14704728, PMID 14744931

NIH funding

2014 (2), 2015 (2), 2017 (2), R01DK062030 (2), 2008 (1), 2009 (1), 2016 (1), 2019 (1), 2023 (1), 2025 (1), K23HL078901 (1), K23HL119622 (1), K23HL148394 (1), P01CA108671 (1), P30CA016672 (1)